Pulmatrix (PULM) Revenue (2014 - 2024)
Pulmatrix (PULM) posted Revenue of $3000.0 for Q4 2024, down 99.18% sequentially from $366000.0 in Q3 2024, and down 99.86% YoY from $2.2 million in Q1 2024.
Pulmatrix (PULM) Revenue (2014 - 2024) Analysis & Trends
Pulmatrix has reported Revenue for 11 years, with the latest figure at $3000.0 in Q4 2024.
- Quarterly Revenue fell 99.86% year-over-year to $3000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $7.8 million (up 6.96% YoY) and the FY2024 annual result came in at $7.8 million, up 6.96% from the prior year.
- Revenue eased to $3000.0 in Q4 2024 per PULM's latest filing, from $366000.0 in the prior quarter.
- Over five years, Revenue peaked at $5.9 million in Q1 2024 and troughed at $3000.0 in Q4 2024.
- A 5-year average of $1.9 million and a median of $1.7 million in 2022 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 292.6% in 2024, down 99.86% in 2024.
- Over 5 years, Revenue stood at $2.0 million in 2020, then slumped by 77.2% to $456000.0 in 2021, then soared by 274.56% to $1.7 million in 2022, then advanced by 28.92% to $2.2 million in 2023, then tumbled by 99.86% to $3000.0 in 2024.
- According to Business Quant data, Revenue over the past three periods registered $3000.0, $366000.0, and $1.6 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Pulmatrix | 5.66 Mn | 5.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 366,000.00 |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 5.89 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 456,000.00 |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 2.25 Mn |
| Mar 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 4.37 Mn |
| Jun 30, 2020 | 3.50 Mn |
| Mar 31, 2020 | 2.76 Mn |